Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Addict Med. 2020 Jul-Aug;14(4):331–336. doi: 10.1097/ADM.0000000000000592

Fig 1.

Fig 1

a: Patients Who Took Study Medication and Continued TAU After Study Participation

b: Patients Who Completed the Study and Elected to Stop Medication

c: Patients With Early OUD Relapse

d: Patients Who Took Study Medication, Dropped-Out of Treatment, then Re-Engaged in TAU

e: Patients Who Initiated Non-Study Medications in TAU

f: Patients Who Switched Medication